Siegfried Holding
Christian Grob's work experience includes:
- Head Quality Assurance Stability & Services at Siegfried Holding AG since March 2021
- Quality Assurance Manager & Expert Stability Studies at Siegfried Holding AG from September 2014 to March 2021
- Bachelor Thesis at Inselspital Bern from April 2014 to September 2014
- Chemical Laboratory Technician at Roche from August 2006 to July 2009
- Internship Chemical Laboratory Technician Analytics at Kantonslabor Basel-Stadt in August 2008.
Christian Grob's education history includes the following experiences:
From 2011 to 2014, Christian Grob attended Fachhochschule Muttenz, where they pursued a Bachelor of Science (B.Sc.) degree in Chemistry.
In 2010 and 2011, Christian Grob served in the military as a Durchdiener in the Militärdienst. During this time, they obtained training and certification as a Richtstrahlpionier/C1 Fahrer, although no specific field of study is mentioned for this experience.
From 2009 to 2010, Christian Grob attended Berufsmaturitätsschule Olten and earned a Berufsmatur degree. The field of study for this qualification is not specified.
And finally, from 2006 to 2009, Christian Grob worked at F. Hoffmann-La Roche as a Chemielaborant, specializing in Synthesis.
This information provides a chronological overview of Christian Grob's education history, as per the details provided.
This person is not in any teams
Siegfried Holding
1 followers
Siegfried Holding AG is a Switzerland-based life sciences company and active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States and China.